Effect of Sodium Benzoate on Cognitive Function Among Patients With Behavioral and Psychological Symptoms of Dementia
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of Sodium Benzoate on Cognitive Function Among Patients With Behavioral and Psychological Symptoms of Dementia
Authors
Keywords
-
Journal
JAMA Network Open
Volume 4, Issue 4, Pages e216156
Publisher
American Medical Association (AMA)
Online
2021-04-22
DOI
10.1001/jamanetworkopen.2021.6156
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- d-glutamate and Gut Microbiota in Alzheimer’s Disease
- (2020) Chun-Hung Chang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Gut-brain axis: A matter of concern in neuropsychiatric disorders…!
- (2020) Muhammad Naveed et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Use of postmenopausal hormone therapy and risk of Alzheimer’s disease in Finland: nationwide case-control study
- (2019) Hanna Savolainen-Peltonen et al. BMJ-British Medical Journal
- Sodium benzoate for the treatment of behavioral and psychological symptoms of dementia (BPSD): A randomized, double-blind, placebo-controlled, 6-week trial
- (2019) C-H Lin et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The Role of N-Methyl-D-Aspartate Receptor Neurotransmission and Precision Medicine in Behavioral and Psychological Symptoms of Dementia
- (2019) Chieh-Hsin Lin et al. Frontiers in Pharmacology
- Theories of Aging and the Prevalence of Alzheimer’s Disease
- (2019) Kaynara Trevisan et al. Biomed Research International
- Understanding the impact of sex and gender in Alzheimer's disease: A call to action
- (2018) Rebecca A. Nebel et al. Alzheimers & Dementia
- Investigating the Interactive Effects of Sex Steroid Hormones and Brain-Derived Neurotrophic Factor during Adolescence on Hippocampal NMDA Receptor Expression
- (2018) Cushla R. McCarthny et al. International Journal of Endocrinology
- Medications Used for Cognitive Enhancement in Patients With Schizophrenia, Bipolar Disorder, Alzheimer’s Disease, and Parkinson’s Disease
- (2018) Wen-Yu Hsu et al. Frontiers in Psychiatry
- D-Amino Acid Oxidase Inhibition: A New Glutamate Twist for Clozapine Augmentation in Schizophrenia?
- (2018) Paul J. Harrison BIOLOGICAL PSYCHIATRY
- Pharmacokinetic data reduce uncertainty in the acceptable daily intake for benzoic acid and its salts
- (2017) K. Zu et al. REGULATORY TOXICOLOGY AND PHARMACOLOGY
- Sodium Benzoate, a D-Amino Acid Oxidase Inhibitor, Added to Clozapine for the Treatment of Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Trial
- (2017) Chieh-Hsin Lin et al. BIOLOGICAL PSYCHIATRY
- Recent global trends in the prevalence and incidence of dementia, and survival with dementia
- (2016) Martin Prince et al. Alzheimers Research & Therapy
- Effects of sodium benzoate on pre-pulse inhibition deficits and hyperlocomotion in mice after administration of phencyclidine
- (2015) Akiko Matsuura et al. ACTA NEUROPSYCHIATRICA
- Longitudinal Relationships Between Alzheimer Disease Progression and Psychosis, Depressed Mood, and Agitation/Aggression
- (2015) Laura B. Zahodne et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Adjunctive sarcosine plus benzoate improved cognitive function in chronic schizophrenia patients with constant clinical symptoms: A randomised, double-blind, placebo-controlled trial
- (2015) Chun-Yuan Lin et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Effects of sodium benzoate on pre-pulse inhibition deficits and hyperlocomotion in mice after administration of phencyclidine
- (2015) Akiko Matsuura et al. ACTA NEUROPSYCHIATRICA
- NMDA Neurotransmission Dysfunction in Mild Cognitive Impairment and Alzheimer’s Disease
- (2014) Chieh-Hsin Lin et al. CURRENT PHARMACEUTICAL DESIGN
- Benzoate, a D-Amino Acid Oxidase Inhibitor, for the Treatment of Early-Phase Alzheimer Disease: A Randomized, Double-Blind, Placebo-Controlled Trial
- (2013) Chieh-Hsin Lin et al. BIOLOGICAL PSYCHIATRY
- Add-on Treatment of Benzoate for Schizophrenia
- (2013) Hsien-Yuan Lane et al. JAMA Psychiatry
- Sex hormones modulate circulating antioxidant enzymes: Impact of estrogen therapy
- (2013) Francesco Bellanti et al. Redox Biology
- NMDA Neurotransmission Dysfunction in Behavioral and Psychological Symptoms of Alzheimer's Disease
- (2012) Yu-Jhen Huang et al. Current Neuropharmacology
- Relapse Risk after Discontinuation of Risperidone in Alzheimer's Disease
- (2012) D.P. Devanand et al. NEW ENGLAND JOURNAL OF MEDICINE
- Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer’s Association Research Roundtable Workgroup
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- D-Amino acid oxidase controls motoneuron degeneration through D-serine
- (2011) J. Sasabe et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Altered Glutamate Neurotransmission and Behaviour in Dementia: Evidence from Studies of Memantine
- (2010) P. Francis Current Molecular Pharmacology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now